Danaher plans an autonomous AI laboratory for antibody discovery.

Danaher said its first AI-powered autonomous research lab is projected to operate at scale in early 2027. The system will design target-binding molecules such as antibodies, build and test them, then feed the results back into the model for the next round.

The company says the workflow could make molecule discovery eight times faster and increase annual generation of target-binding molecules tenfold. Those are company projections rather than independently demonstrated production results; Danaher presents the laboratory as part of a broader program for connected smart instruments.